SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-050840
Filing Date
2024-04-30
Accepted
2024-04-30 20:58:33
Documents
2
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1647
2 EX-24 cgem-ex24.htm EX-24 12221
  Complete submission text file 0000950170-24-050840.txt   15612
Mailing Address ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Fenton Mary Kay (Reporting) CIK: 0001378589 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39856 | Film No.: 24899613

Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)